Announcement summary
BestHealth4U (BH4U), a Portuguese company developing adhesive technology for skin-contact medical products, announced the close of a $1 million seed financing round in November 2022. Its announcement named Lince Capital as the lead investor in the round and noted an earlier pre-seed investment led by Portugal Ventures.
BH4U said it intended to use the financing to continue development of Bio2Skin, work through regulatory processes in Europe and the United States, expand its team, and develop partnerships with adhesive and medical-device manufacturers. Those were stated plans at the time, not proof of later approval or commercialization.
The company described Bio2Skin as a technology intended for products used in prolonged contact with skin. Medical-device performance and availability should be assessed through current regulatory and clinical information; a funding announcement is not evidence that a product is approved or effective for a particular patient.
The announcement was distributed through Get News on November 3, 2022. Its title referred to planned market-entry work in 2023.